The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Sandoz GmbH Kundl, Tirol, Austria Manufacturing locations: Austria and Germany www.sandoz.com DRUG LIFE CYCLE STAGES: Research & Development — clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production SERVICES OFFERED: Aseptic fill/finish, cytotoxic & high-potency compounds, generics, injectables, liquids, peptides, proteins, and small molecules. "Sandoz is honored to be recognized once again with the CMO Award. We are grateful to our customers and look forward to many more decades of working with them to bring important medicines to patients. We have a distinguished history as a global leader in contract manufacturing — both in fermentation-derived intermediates and APIs, and recombinant proteins and peptides (microbial and mammalian). We are also thankful for our great people, whose collaborative approach has been a key driver of our success." — Friedrich Nachtmann, head of biotech cooperations; and Gerhard Santer, head of global development and strategy Solvias Kaiseraugst, Switzerland Manufacturing locations: Basel, Switzerland www.solvias.com (908) 249-7693 DRUG TYPE: Pharmaceuticals Contact: Ron Yarger ron.yarger@solvias.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, clinical (phase 1 and phase 2); Drug Substance Production — primary process development and drug substance production SERVICES OFFERED: APIs and intermediates. "We offer increased capacity and profound know-how for analytical and chemical development. Our strong portfolio of services and products can accommodate the full spectrum of our customers' requirements — from initial drug characterization, through analytical and chemical process development capabilities, to release testing and production support. We develop flexible, customized solutions that meet our customers' specific drug-development criteria." — Dr. Hansjörg Walther, CEO DRUG TYPE: Pharmaceuticals Takeda Pharma Roskilde, Denmark Manufacturing locations: Austria, Brazil, China, Germany, Mexico, Poland, and Russia www.takeda.com Contact: Kim Wochner kim.wochner@takeda.com DRUG LIFE CYCLE STAGES: Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics. SERVICES OFFERED: Capsules, cartridges, controlled substances, creams & ointments, compounds, gels, generics, liquids, nonsterile, OTC, powders (nonsterile), semisolids, soft gels, solid dose, solutions & suspensions, sterile, and syringes (prefilled). "Takeda is very proud of receiving this award within the areas of quality and reliability. We believe this is a key to success within contract manufacturing. Our consistent focus over the years in building quality in everything we do has with this award been recognized by our clients and the industry. Many years within pharmaceutical production and long-lasting partnerships have demonstrated the reliability in our services. Thank you all for this award." — Kim Wochner, director, contract manufacturing business The CMO Leadership Awards 2013 45